| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 01/16/2013 | CN101906105B Pyrazolo (1,5-a) pyrimidone derivative as well as drug combination thereof and application thereof |
| 01/16/2013 | CN101857597B Diethylene triamine pentaacetic acid or ethylene diamine tetraacetic acid or amine triacetic acid modified porphyrin, preparation method and application thereof |
| 01/16/2013 | CN101115755B Pyrazolo-pyrimidine derivatives as MGLUR2 antagonists |
| 01/15/2013 | US8354532 Pyrrolo [2,3-D] pyrimidines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV |
| 01/15/2013 | US8354414 Substituted bicyclic pyrimidines |
| 01/15/2013 | US8354408 N-containing heterocyclic compounds |
| 01/15/2013 | US8354405 6-cycloamino-3-(pyrid-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 01/15/2013 | CA2689092C Raf kinase modulators and methods of use |
| 01/15/2013 | CA2666696C Salts of pyrrolopyrimidinone derivatives and process for preparing the same |
| 01/10/2013 | WO2013006738A1 Compounds for the treatment of hiv |
| 01/10/2013 | WO2013006526A2 Tricyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors |
| 01/10/2013 | WO2013006485A1 Fused benzoxazepinones as ion channel modulators |
| 01/10/2013 | WO2013005798A1 Novel nitrogenated heterocyclic ring derivative |
| 01/10/2013 | WO2013004551A1 Hydroxymethylaryl-substituted pyrrolotriazines as alk1 inhibitors |
| 01/10/2013 | WO2013003912A1 Cryptate compounds |
| 01/10/2013 | WO2012138255A3 Tricyclic derivatives of ν,ν'-substituted 3,7-diazabicyclo [3.3.1]nonanes and drugs based thereon |
| 01/10/2013 | WO2012092484A3 Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections |
| 01/10/2013 | WO2012085665A3 Novel processes for preparing triazolo[4,5-d]pyrimidine derivatives and intermediates thereof |
| 01/10/2013 | US20130012721 Methods for the purification of cucurbituril |
| 01/10/2013 | US20130012719 Convenient Synthesis of Azolines to Azoles |
| 01/10/2013 | US20130012707 Process for synthesizing 6-bromo-3-1-(1-methyl-1h-pyrazol-4-yl)-5-(3(r)-piperidinyl)pyrazolo[1,5-a]pyrimidin-7-amine |
| 01/10/2013 | US20130012706 Methods and Intermediates for the Synthesis of 4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazines |
| 01/10/2013 | US20130012700 Materials for organic electroluminescent devices |
| 01/10/2013 | US20130012597 Temperature-, ph- or salt concentration-sensitive separation material and use thereof |
| 01/10/2013 | US20130012516 6-CYCLOAMINO-3-(PYRID-4-YL)IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF |
| 01/10/2013 | US20130012515 Fused Bicyclic Pyridine and Pyrazine Derivatives as Kinase Inhibitors |
| 01/10/2013 | US20130012511 Soluble guanylate cyclase activators |
| 01/10/2013 | US20130012507 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/10/2013 | US20130012498 5ht2c receptor modulators |
| 01/10/2013 | US20130012496 Benzazepine compound |
| 01/10/2013 | US20130012495 5ht2c receptor modulators |
| 01/10/2013 | US20130012492 Fused heterocyclic compounds as ion channel modulators |
| 01/10/2013 | US20130012490 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
| 01/10/2013 | US20130012485 Organic compounds |
| 01/10/2013 | US20130012434 Novel spiro imidazolones as glucagon receptor antagonists, compositions, and methods for their use |
| 01/10/2013 | US20130011901 Cyclic compound, method for producing cyclic compound, and method for modifying biological molecule |
| 01/10/2013 | US20130009142 Charge transport compositions and electronic devices made with such compositions |
| 01/10/2013 | US20130008503 Organic photovoltaic devices comprising solution-processed substituted metal-phthalocyanines and exhibiting near-ir photo-sensitivity |
| 01/10/2013 | CA2840518A1 Hydroxymethylaryl-substituted pyrrolotriazines as alk1 inhibitors |
| 01/10/2013 | CA2840095A1 Compounds for the treatment of hiv |
| 01/10/2013 | CA2838223A1 Fused benzoxazepinones as ion channel modulators |
| 01/09/2013 | EP2543670A1 Pyrazolopyrimidine derivative |
| 01/09/2013 | EP2543667A1 2-aminopyridine analogs as glucokinase activators |
| 01/09/2013 | EP2543380A1 Neural stem cells proliferation promoting agent |
| 01/09/2013 | EP2543375A1 Pyrrolo-pyrimidine analogues as inhibitors of bruton's tyrosine kinase |
| 01/09/2013 | EP2542554A1 Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
| 01/09/2013 | EP2542553A1 Methods and intermediates for the synthesis of 4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazines |
| 01/09/2013 | EP2542552A1 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators |
| 01/09/2013 | EP2542545A1 Inhibitors of hepatitis c virus ns5b polymerase |
| 01/09/2013 | EP2542537A1 Novel compounds for modulation of orphan nuclear receptor rar-related orphan receptor-gamma (ror gamma, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune disease |
| 01/09/2013 | EP2542524A1 Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 01/09/2013 | CN102869666A Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/09/2013 | CN102869665A Benzazepine compound |
| 01/09/2013 | CN102869664A Pyrazolopyrimidine kinase inhibitors |
| 01/09/2013 | CN102869663A Pyrazolopyrazine kinase inhibitors |
| 01/09/2013 | CN102869662A Organic electroluminescence devices |
| 01/09/2013 | CN102869661A Anti-infective compounds |
| 01/09/2013 | CN102863450A Novel compound for detecting hexanal exhaled by lung cancer patient |
| 01/09/2013 | CN102863449A Method for preparing graphene/metal phthalocyanine composite based on microwave synthesis method |
| 01/09/2013 | CN102863448A Soluble phthalocyanine compound and preparation method thereof, and organic thin film transistor |
| 01/09/2013 | CN102863447A Imidazole chiral organic small molecular compound with dual-loop structure and synthetic method thereof |
| 01/09/2013 | CN102863446A Preparation of pyrrole and pyrrolin fused ring compound with insecticidal activity and use thereof |
| 01/09/2013 | CN102863441A Clic central nervous system active agents |
| 01/09/2013 | CN102863387A Novel synthetic method for imidazole onium salts |
| 01/09/2013 | CN101400655B Quinolone derivative or pharmaceutically acceptable salt thereof |
| 01/08/2013 | US8349869 Macrocylic inhibitors of hepatitis C virus |
| 01/08/2013 | US8349860 Inhibitors of syk and JAK protein kinases |
| 01/08/2013 | US8349858 Polycyclic guanine derivatives and use thereof |
| 01/08/2013 | US8349848 Pyrrolo[3,2-D]pyrimidines that are selective antagonists of A2B adenosine receptors |
| 01/08/2013 | US8349847 Pyrazolo [3,4-D] pyrimidine derivatives as anti-cancer agents |
| 01/08/2013 | US8349844 Substituted pyrazolo [1,5-A] pyrimidines as metabotropic glutamate antagonists |
| 01/08/2013 | US8349843 Carboxylic acid derivatives, their preparation and use |
| 01/08/2013 | US8349473 Organic electroluminescent device |
| 01/08/2013 | US8349335 Methods for preparing chlorophyll a and chlorin e6 |
| 01/08/2013 | CA2742783C Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 01/08/2013 | CA2696826C Process for preparing inhibitors of nucleoside metabolism |
| 01/08/2013 | CA2662000C Thiophene pyrazolopyrimidine compounds |
| 01/08/2013 | CA2590333C Tetracyclic imidazo-benzodiazepines as gaba receptors modulators |
| 01/08/2013 | CA2543318C Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto |
| 01/08/2013 | CA2527420C Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 01/08/2013 | CA2526530C (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent |
| 01/03/2013 | WO2013003586A1 Quinazolines as therapeutic compounds and related methods of use |
| 01/03/2013 | WO2013003298A2 Inhibitors of pde10 |
| 01/03/2013 | WO2013001514A1 Solid dispersions of sitagliptin and processes for their preparation |
| 01/03/2013 | WO2013001457A1 Novel salts of sitagliptin |
| 01/03/2013 | WO2013001310A1 Macrocyclic compounds and their use as cdk8 inhibitors |
| 01/03/2013 | WO2013000924A1 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES |
| 01/03/2013 | WO2012135615A3 Enopeptins, uses thereof, and methods of synthesis thereto |
| 01/03/2013 | US20130005970 Method for the production of beta-ketonitriles |
| 01/03/2013 | US20130005917 Process for producing chemically functionalized nano graphene materials |
| 01/03/2013 | US20130001522 Heterocyclic compound and organic light-emitting device including the same |
| 01/03/2013 | CA2840814A1 Solid dispersions of sitagliptin and processes for their preparation |
| 01/03/2013 | CA2840806A1 Novel salts of sitagliptin |
| 01/03/2013 | CA2840627A1 Quinazolines as therapeutic compounds and related methods of use |
| 01/03/2013 | CA2838645A1 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives |
| 01/02/2013 | EP2540821A1 Method for producing regulatory dendritic cells |
| 01/02/2013 | EP2540727A1 Sulfamoylating reagent |
| 01/02/2013 | EP2540726A1 Intermediates for the synthesis of E1 activity activating enzyme inhibitors |
| 01/02/2013 | EP2540706A2 Process for preparing indol-5-oxy-quinazoline derivatives and intermediates |
| 01/02/2013 | EP2540705A2 Process for preparing indol-5-oxy-quinazoline derivatives and intermediates |